The industrial instruments manufacturer saw its shares more than double on its first day of trading, prompting investor debate over whether to buy, sell, or hold the newly listed stock.

The allotment for the Tempsens Instruments India IPO is scheduled for today, with investors able to check their status on BSE, NSE, and the registrar's website. Grey Market Premium (GMP) signals strong interest in the offering.

The grey market premium for Tempsens Instruments' IPO has surged by over 100%, marking the first IPO to cross this milestone in nearly two years and indicating strong investor interest.

Tempsens Instruments is planning an initial public offering (IPO) of ₹650 crore to fund its expansion initiatives and repay existing debt.

Indian medical device manufacturer Tempsens Instruments saw its shares jump 110% on its first day of trading, marking the strongest IPO debut in India this year.

Investors monitor the allotment results for the Tempsens Instruments IPO on major Indian exchanges, with grey market premiums indicating strong demand ahead of listing.

Gaja Capital's IPO was subscribed 31 times on its third day, while Tempsens Instruments' IPO was subscribed over 21 times on its second day, indicating significant investor interest in both offerings.

Tempsens Instruments (India) Ltd. has announced its Initial Public Offering, inviting investors to subscribe to its shares.

The Initial Public Offering (IPO) for Tempsens Instruments was subscribed more than 28 times over by its third day, with its Grey Market Premium (GMP) signaling strong listing gains.

The Initial Public Offering (IPO) of Tempsens Instruments saw strong demand, being subscribed six times over on its first day, with a Grey Market Premium (GMP) of 73%.